US 11299736
Conjugated antisense compounds and their use
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 11299736 (Conjugated antisense compounds and their use) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K47/549, A61K47/59